Chronic lymphocytic leukaemia trials in Puerto Rico

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

  Where

  San Juan

  Age

  18 years and over

  People

  735 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT05947851 · EU 2022-501560-17-00
• Phase 3Taking people
  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  Where

  San Juan

  Age

  18 years and over

  People

  500 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT06973187 · EU 2025-522860-34-00
• Phase 3Taking people
  A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

  Where

  Rio Piedras

  Age

  18 years and over

  People

  170 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06428019 · EU 2024-512147-23-00